SCHEMBL7669409

SCHEMBL7669409

O=c1c(Cc2cccnc2)cn2c3ccc(Br)cc3/c(=N\O)c3cc(OCc4cccnc4)cc1c32

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.35
GABRA5 P31644 1/20 0.35
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
PKM P14618 2/20 0.33
HIF1A Q16665 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
FPR1 P21462 1/20 0.33
FPR2 P25090 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GRM2 Q14416 1/20 0.33
MAPK1 P28482 1/20 0.32
LRRK2 Q5S007 1/20 0.32
TBXAS1 P24557 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669413 1.00 GABRA1 (0.35) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7666407 0.93 GABRA1 (0.35) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7666416 0.93 GABRA1 (0.35) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7662030 0.91 GABRA1 (0.34) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7662032 0.91 GABRA1 (0.34) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL6979179 0.91 GABRA1 (0.39) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7673377 0.91 GABRA1 (0.39) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7674687 0.88 MEN1 (0.31) GABRA1GABRA5PKMMEN1KMT2A
SCHEMBL6982487 0.87 LRRK2 (0.38) GABRA1GABRA5ALDH1A1MAPTPKM
SCHEMBL7668195 0.87 LTA4H (0.44) ALDH1A1MEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed